D. Peabody

发表

Mutations in the hydrophobic core and in the protein-RNA interface affect the packing and stability of icosahedral viruses.

Jerson L. Silva, S. Lima, D. Peabody, 2003, European journal of biochemistry.

Crystal structures of a series of RNA aptamers complexed to the same protein target

A. Ellington, S. Phillips, P. Stockley, 1998, Nature Structural Biology.

Translation initiation at non-AUG triplets in mammalian cells.

D. Peabody, D S Peabody, 1989, The Journal of biological chemistry.

The Targeted Delivery of Multicomponent Cargos to Cancer Cells via Nanoporous Particle-Supported Lipid Bilayers

Mark B. Carter, Cheryl L. Willman, C. Jeffrey Brinker, 2011, Nature materials.

Cell-specific delivery of diverse cargos by bacteriophage MS2 virus-like particles.

Mark B. Carter, Genevieve K Phillips, C Jeffrey Brinker, 2011, ACS nano.

Cell-Speci fi cDelivery of Diverse Cargos byBacteriophageMS 2 Virus-likeParticles

Mark B. Carter, Eric C. Carnes, C. Brinker, 2011 .

Erratum: The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers (Nature Materials (2011) 10 (389-397))

Mark B. Carter, Cheryl L. Willman, C. Jeffrey Brinker, 2011 .

Author ' s personal copy

D. Peabody, B. Chackerian, Julianne Peabody, 2007 .

Optimized Formulation of a Thermostable Spray-Dried Virus-Like Particle Vaccine against Human Papillomavirus.

D. Peabody, B. Chackerian, Pavan Muttil, 2016, Molecular pharmaceutics.

Preclinical refinements of a broadly protective VLP-based HPV vaccine targeting the minor capsid protein, L2.

D. Peabody, B. Chackerian, Pavan Muttil, 2015, Vaccine.

Mutations that increase the affinity of a translational repressor for RNA.

D. Peabody, F. Lim, 1994, Nucleic acids research.

Immunogenic display of diverse peptides, including a broadly cross-type neutralizing human papillomavirus L2 epitope, on virus-like particles of the RNA bacteriophage PP7.

J. Schiller, D. Peabody, B. Chackerian, 2010, Vaccine.

VLPs Displaying a Single L2 Epitope Induce Broadly Cross-Neutralizing Antibodies against Human Papillomavirus

D. Peabody, B. Chackerian, Julianne Peabody, 2012, PloS one.

A universal virus-like particle-based vaccine for human papillomavirus: longevity of protection and role of endogenous and exogenous adjuvants.

D. Peabody, B. Chackerian, Julianne Peabody, 2013, Vaccine.

Charge neutralization as the major factor for the assembly of nucleocapsid-like particles from C-terminal truncated hepatitis C virus core protein

D. Ferreira, Jerson L. Silva, M. L. Bianconi, 2016, PeerJ.

Vaccination with VLPs Presenting a Linear Neutralizing Domain of S. aureus Hla Elicits Protective Immunity

D. Peabody, P. Hall, Seth M. Daly, 2020, Toxins.

Structural studies of MS2 bacteriophage virus particle disassembly by nuclear magnetic resonance relaxation measurements.

F. Almeida, A. Valente, J. Silva, 2003, Biophysical journal.

VLP-based vaccine induces immune control of Staphylococcus aureus virulence regulation

D. Peabody, K. Frietze, P. Hall, 2017, Scientific Reports.

Delivery of Ricin Toxin A‐Chain by Peptide‐Targeted Mesoporous Silica Nanoparticle‐Supported Lipid Bilayers

Jason L. Townson, Dan C. Wilkinson, Eric C. Carnes, 2012, Advanced healthcare materials.

Assessing Antibody Specificity in Human Serum Using Deep Sequence-Coupled Biopanning.

D. Peabody, K. Frietze, B. Chackerian, 2020, Methods in molecular biology.

Pathogen-specific deep sequence-coupled biopanning: A method for surveying human antibody responses

J. Pascale, D. Peabody, K. Frietze, 2017, PloS one.

Translation initiation at an ACG triplet in mammalian cells.

D. Peabody, 1987, The Journal of biological chemistry.

Factors That Govern the Induction of Long-Lived Antibody Responses

D. Peabody, B. Chackerian, 2020, Viruses.

The RNA-binding Site of Bacteriophage Qβ Coat Protein*

D. Peabody, F. Lim, M. Spingola, 1996, The Journal of Biological Chemistry.

Expansion and Refinement of Deep Sequence-Coupled Biopanning Technology for Epitope-Specific Antibody Responses in Human Serum

J. Pascale, D. Peabody, K. Frietze, 2020, Viruses.

RNA Phage VLP-Based Vaccine Platforms

Steven B. Bradfute, D. Peabody, B. Chackerian, 2021, Pharmaceuticals.

Thermal Stability of RNA Phage Virus-Like Particles Displaying Foreign Peptides

D. Peabody, J. Caldeira, 2011, Journal of nanobiotechnology.

Encapsidation of heterologous RNAs by bacteriophage MS2 coat protein.

D. Peabody, G. Pickett, 1993, Nucleic acids research.

Antibodies to Variable Domain 4 Linear Epitopes of the Chlamydia trachomatis Major Outer Membrane Protein Are Not Associated with Chlamydia Resolution or Reinfection in Women

C. Wheeler, D. Peabody, K. Frietze, 2020, Msphere.

Crystal structure of an RNA aptamer–protein complex at 2.8 Å resolution

A. Ellington, J. Murray, S. Phillips, 1998, Nature Structural Biology.

Delivery of small interfering RNA by peptide-targeted mesoporous silica nanoparticle-supported lipid bilayers.

Jason L. Townson, Dan C. Wilkinson, Eric C. Carnes, 2012, ACS nano.

A Pan-HPV Vaccine Based on Bacteriophage PP7 VLPs Displaying Broadly Cross-Neutralizing Epitopes from the HPV Minor Capsid Protein, L2

D. Peabody, B. Chackerian, Julianne Peabody, 2011, PloS one.

Engineering virus-like particles as vaccine platforms.

D. Peabody, K. Frietze, B. Chackerian, 2016, Current opinion in virology.

Affinity selection of epitope-based vaccines using a bacteriophage virus-like particle platform.

D. Peabody, B. Chackerian, J. O’Rourke, 2015, Current opinion in virology.

The use of hybrid virus‐like particles to enhance the immunogenicity of a broadly protective HPV vaccine

D. Peabody, B. Chackerian, Ebenezer Tumban, 2014, Biotechnology and bioengineering.

Development of a Mimotope Vaccine Targeting the Staphylococcus aureus Quorum Sensing Pathway

D. Peabody, P. Hall, Seth M. Daly, 2014, PloS one.

Immunization with a consensus epitope from human papillomavirus L2 induces antibodies that are broadly neutralizing.

M. Ozbun, D. Peabody, A. Dziduszko, 2014, Vaccine.

Epitope-Specific Anti-hCG Vaccines on a Virus Like Particle Platform

D. Peabody, B. Chackerian, J. Caldeira, 2015, PloS one.

Qß Virus-like particle-based vaccine induces robust immunity and protects against tauopathy

Colin M. Wilson, J. Brigman, D. Peabody, 2019, npj Vaccines.

Immunogenic display of diverse peptides on virus-like particles of RNA phage MS2.

D. Peabody, B. Chackerian, Brett C. Manifold-Wheeler, 2008, Journal of molecular biology.

Virus and virus-like particle-based immunogens for Alzheimer's disease induce antibody responses against amyloid-beta without concomitant T cell responses.

D. Peabody, B. Chackerian, Zoe N Hunter, 2006, Vaccine.

Effect of upstream reading frames on translation efficiency in simian virus 40 recombinants

D. Peabody, P. Berg, S. Subramani, 1986, Molecular and cellular biology.

Termination-reinitiation occurs in the translation of mammalian cell mRNAs

D. Peabody, P. Berg, 1986, Molecular and cellular biology.

SV40 T antigen alone drives karyotype instability that precedes neoplastic transformation of human diploid fibroblasts

L. S. Cram, D. Peabody, P. Kraemer, 1990, Journal of cellular biochemistry.

Determinants of translation efficiency of specific mRNAs in mammalian cells.

D. Peabody, 1990, Genetic engineering.

Crystal structure of the MS2 coat protein dimer: implications for RNA binding and virus assembly.

R. Kodandapani, C. Ni, K. R. Ely, 1995, Structure.

Cell-specific delivery by bacteriophage Single-molecule trapping Biofunctional quantum dots

Mark B. Carter, Eric C. Carnes, C. Brinker, 2011 .

Identification and Immunological Characterization of the Ligand Domain of Plasmodium vivax Reticulocyte Binding Protein 1a

D. Peabody, C. King, B. Chackerian, 2018, The Journal of infectious diseases.

Qß Virus-like particle-based vaccine induces robust immunity and protects against tauopathy

Colin M. Wilson, J. Brigman, D. Peabody, 2019, npj Vaccines.

Role of the coat Protein-RNA interaction in the life cycle of bacteriophage MS2

D. Peabody, D. S. Peabody, 1997, Molecular and General Genetics MGG.

The RNA binding site of bacteriophage MS2 coat protein.

D. Peabody, D S Peabody, 1993, The EMBO journal.

Complementation of RNA binding site mutations in MS2 coat protein heterodimers.

D. Peabody, F. Lim, 1996, Nucleic acids research.

Engineering an Antibody V Gene-Selective Vaccine

Larance Ronsard, D. Lingwood, D. Rohrer, 2021, Frontiers in Immunology.

Stability and assembly in vitro of bacteriophage PP7 virus-like particles

D. Peabody, J. Caldeira, 2007, Journal of nanobiotechnology.

A Viral Platform for Chemical Modification and Multivalent Display

D. Peabody, 2003, Journal of nanobiotechnology.

Recognition of diverse RNAs by a single protein structural framework.

D. Peabody, F. Lim, M. Spingola, 2002, Archives of biochemistry and biophysics.

Translational Repression and Specific RNA Binding by the Coat Protein of the Pseudomonas Phage PP7*

D. Peabody, F. Lim, Thomas P. Downey, 2001, The Journal of Biological Chemistry.

MS2 coat protein mutants which bind Qbeta RNA.

D. Peabody, M. Spingola, Marc Spingola, 1997, Nucleic acids research.

Crystal structure of the coat protein from the GA bacteriophage: Model of the unassembled dimer

R. Kodandapani, C. Ni, K. R. Ely, 1996, Protein science : a publication of the Protein Society.

Altering the RNA binding specificity of a translational repressor.

D. Peabody, F. Lim, M. Spingola, 1994, The Journal of biological chemistry.

Control of translational repression by protein-protein interactions.

D. Peabody, K. R. Ely, 1992, Nucleic acids research.

Dissecting the role of protein–protein and protein–nucleic acid interactions in MS2 bacteriophage stability

Jerson L. Silva, Andréa C. Oliveira, D. Peabody, 2006, The FEBS journal.

Isolation of viral coat protein mutants with altered assembly and aggregation properties.

D. Peabody, D S Peabody, L Al-Bitar, 2001, Nucleic acids research.

Structural basis of RNA binding discrimination between bacteriophages Qbeta and MS2.

S. Phillips, L. Liljas, P. Stockley, 2006, Structure.

The limits of specificity: An experimental analysis with RNA aptamers to MS2 coat protein variants

A. Ellington, D. Peabody, I. Hirao, 2004, Molecular diversity.

RNA recognition site of PP7 coat protein.

D. Peabody, F. Lim, 2002, Nucleic acids research.

Asymmetric interactions in the adenosine-binding pockets of the MS2 coat protein dimer

A. J. Powell, D. Peabody, 2001, BMC Molecular Biology.

Translational repression by bacteriophage MS2 coat protein expressed from a plasmid. A system for genetic analysis of a protein-RNA interaction.

D. Peabody, 1990, The Journal of biological chemistry.

The Immunogenicity of a VLP-based Malaria Vaccine Targeting CSP in Pregnant and Neonatal Mice

D. Peabody, B. Chackerian, L. Jelinkova, 2023, Biomolecules.

A malaria vaccine candidate based on an epitope of the Plasmodium falciparum RH5 protein

D. Peabody, B. Chackerian, R. Ord, 2014, Malaria Journal.

The E. coli Rho protein: an ATPase that terminates transcription.

D. Bear, D. Peabody, 1988, Trends in biochemical sciences.

Subunit fusion confers tolerance to peptide insertions in a virus coat protein.

D. Peabody, 1997, Archives of biochemistry and biophysics.

Convective assembly of 2D lattices of virus-like particles visualized by in-situ grazing-incidence small-angle X-ray scattering.

Eric C. Carnes, C. Brinker, O. Velev, 2011, Small.

Hydrostatic Pressure as a Tool to Study Virus Assembly: Pressure-Inactivation of Viruses by Formation of Fusion Intermediate States

D. Foguel, F. Almeida, A. Valente, 1999 .

Obligatory hybridization of heterologous immunoglobulin light chains into covalently linked dimers.

K. R. Ely, A. Edmundson, D. Peabody, 1980, Biochemistry.

A method for mapping the linear epitopes targeted by the natural antibody response to Zika virus infection using a VLP platform technology.

Steven B. Bradfute, J. Pascale, D. Peabody, 2023, Virology.

Identification of Anti-CA125 Antibody Responses in Ovarian Cancer Patients by a Novel Deep Sequence–Coupled Biopanning Platform

R. Roden, D. Peabody, B. Chackerian, 2015, Cancer Immunology Research.

Identification of an Immunogenic Mimic of a Conserved Epitope on the Plasmodium falciparum Blood Stage Antigen AMA1 Using Virus-Like Particle (VLP) Peptide Display

D. Peabody, B. Chackerian, D. Narum, 2015, PloS one.

Peptide epitope identification by affinity selection on bacteriophage MS2 virus-like particles.

D. Peabody, B. Chackerian, Bryce Chackerian, 2011, Journal of molecular biology.

Viral nanoparticles donning a paramagnetic coat: conjugation of MRI contrast agents to the MS2 capsid.

Kent Kirshenbaum, K. Kirshenbaum, D. Peabody, 2006, Nano letters.

Surface plasmon enhanced fluorescence emission inside metal nanoshells

C. Brinker, I. Brener, S. Xiong, 2010, CLEO/QELS: 2010 Laser Science to Photonic Applications.

A plasmid vector and quantitative techniques for the study of transcription termination in Escherichia coli using bacterial luciferase.

T. Baldwin, D. Bear, D. Peabody, 1989, Gene.

Bacteriophage Virus-Like Particles as a Platform for Vaccine Discovery

D. Peabody, B. Chackerian, 2015 .

Display of single-chain variable fragments on bacteriophage MS2 virus-like particles

D. Peabody, Christopher A. Lino, J. Caldeira, 2017, Journal of Nanobiotechnology.

Mobile Fc region in the Zie IgG2 cryoglobulin: comparison of crystals of the F(ab')2 fragment and the intact immunoglobulin.

K. R. Ely, E. Abola, P. Colman, 1978, Biochemistry.

Asymmetric Contributions to RNA Binding by the Thr45Residues of the MS2 Coat Protein Dimer*

D. Peabody, A. Chakerian, 1999, The Journal of Biological Chemistry.

Affinity selection of epitope-based vaccines using a bacteriophage virus-like particle platform.

D. Peabody, B. Chackerian, J. O’Rourke, 2015, Current opinion in virology.

Engineering virus-like particles as vaccine platforms.

D. Peabody, B. Chackerian, Kathryn M. Frietze, 2016, Current opinion in virology.

Accessible intrachain disulfide bonds in hybrids of light chains.

B. Cheson, A. Edmundson, D. Peabody, 1985, Molecular immunology.

A universal virus-like particle-based vaccine for human papillomavirus: longevity of protection and role of endogenous and exogenous adjuvants.

D. Peabody, B. Chackerian, Julianne Peabody, 2013, Vaccine.

Translational repression by bacteriophage MS2 coat protein does not require cysteine residues.

D. Peabody, 1989, Nucleic acids research.